Related Experiment Video
Updated: Jul 4, 2026
08:15
Gastrointestinal Motility Monitor (GIMM)
Published on: December 2, 2010
NSAIDs and the GI tract-potential hazards and benefits
1Division of Gastroenterology, Department of Medicine, C Floor, South Block, University Hospital Nottingham, Nottingham NG72UH, UK.
Apoptosis : an International Journal on Programmed Cell Death
|November 25, 2003
Summary
Aspirin and non-aspirin non-steroidal anti-inflammatory drugs (NSAIDs) offer gastrointestinal benefits, potentially preventing cancer, but also carry risks like ulcers. Their dual effects may stem from apoptosis promotion, independent of prostaglandin inhibition.
Area of Science:
- Gastroenterology
- Pharmacology
- Oncology
Background:
- Non-steroidal anti-inflammatory drugs (NSAIDs), including aspirin, significantly impact the gastrointestinal tract.
- NSAID use is associated with both therapeutic benefits and considerable toxicity.
Purpose of the Study:
- To explore the dual impact of NSAIDs on gastrointestinal health, focusing on toxicity and anti-cancer benefits.
- To investigate the underlying mechanisms, including prostaglandin synthesis inhibition and apoptosis promotion.
Main Methods:
- Review of existing literature on NSAID effects on the gastrointestinal tract.
- Analysis of mechanisms contributing to both NSAID toxicity and anti-cancer properties.
Main Results:
- Major NSAID toxicity includes gastroduodenal ulceration and intestinal injury.
- NSAIDs demonstrate potential in preventing, delaying, or regressing gastrointestinal malignancies, particularly in the colon and stomach.
- Prostaglandin synthesis inhibition is linked to NSAID toxicity, but not fully explanatory of anti-cancer effects.
Conclusions:
- Apoptosis promotion, potentially independent of prostaglandin synthesis, may explain NSAID's therapeutic benefits and some toxicities.
- Understanding these mechanisms is crucial for optimizing NSAID use in gastrointestinal health and cancer prevention.
More Related Videos
Related Concept Videos
01:24Drugs for Peptic Ulcer Disease: Sucralfate as Mucosal Protective Agents
In the intricate landscape of the gastric lumen, excessive acid secretion disrupts the natural defense mechanisms, weakening the mucus-bicarbonate barrier. This vulnerability allows pepsin to infiltrate epithelial cells, digesting mucosal proteins and triggering erosion, leading to ulcer formation.
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
In this scenario, mucosal protective agents like sucralfate play an essential role. Sucralfate, a complex of sulfated sucrose and aluminum hydroxide, demonstrates its usefulness in acidic conditions,...
01:20Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
The gastric mucosa produces prostaglandins E2 (PGE2) and prostacyclin (PGI2), crucial in maintaining gastric health. They exert cytoprotective effects, including increasing bicarbonate secretion, releasing protective mucin, reducing gastric acid output, and preventing harmful vasoconstriction. These effects are mediated through various receptors, such as EP1, EP2, EP3, and EP4.
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
01:17Drugs Affecting GI Tract Motility: Opioids as Antidiarrheal Agents
Diarrhea, a condition marked by frequent loose or watery bowel movements, can be triggered by multiple factors such as viral or bacterial infections, food intolerances, anxiety, medications, and digestive disorders. Symptoms may include abdominal pain, bloating, nausea, and cramping. Severe or prolonged diarrhea can lead to complications like electrolyte imbalances, malnutrition, and dehydration if left untreated.
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
Opioids, widely used antidiarrheal agents, mitigate diarrhea by slowing down...
01:18Drugs Affecting GI Tract Motility: Antimicrobials as Antidiarrheal Agents
Acute diarrhea, a common gastrointestinal disturbance, is characterized by the rapid evacuation of fluid stools, leading to an excessive weight in fluid. This condition typically arises from disorders affecting intestinal water and electrolyte transport. It can be triggered by an increased osmotic load within the intestine, excessive secretion of electrolytes and water, mucosal exudation of protein and fluid, or altered intestinal motility. The primary risks of acute diarrhea are dehydration...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:30Drug toxicity: Drug–Drug Interaction
Drug–drug interactions can precipitate toxicity through multiple mechanisms. Absorption interactions alter how drugs enter the body, exemplified when ranitidine increases the absorption of basic drugs, while cholestyramine decreases the levels of propranolol. Protein binding interactions occur when drugs share the same binding sites on plasma proteins. Drugs like aspirin and warfarin, when bound in excess, can lead to increased free drug concentrations, enhancing the potential for...